|
|
negative regulation of striated muscle tissue development
|
GO:0045843 |
11 |
0.989
|
|
|
|
mesodermal cell fate specification
|
GO:0007501 |
2 |
0.988
|
|
|
|
mesodermal cell fate commitment
|
GO:0001710 |
2 |
0.987
|
|
|
|
embryonic forelimb morphogenesis
|
GO:0035115 |
4 |
0.985
|
|
|
|
cardiac right ventricle formation
|
GO:0003219 |
1 |
0.981
|
|
|
|
embryonic camera type eye formation
|
GO:0060900 |
2 |
0.978
|
|
|
|
positive regulation of monocyte chemotactic protein 1 production
|
GO:0071639 |
3 |
0.971
|
|
|
|
cardiac chamber formation
|
GO:0003207 |
2 |
0.962
|
|
|
|
cardiac ventricle formation
|
GO:0003211 |
2 |
0.960
|
|
|
|
embryonic camera type eye development
|
GO:0031076 |
2 |
0.947
|
|
|
|
aortic valve development
|
GO:0003176 |
3 |
0.944
|
|
|
|
neural crest cell development
|
GO:0014032 |
3 |
0.931
|
|
|
|
blood vessel maturation
|
GO:0001955 |
1 |
0.925
|
|
|
|
hindbrain development
|
GO:0030902 |
3 |
0.899
|
|
|
|
forelimb morphogenesis
|
GO:0035136 |
4 |
0.883
|
|
|
|
hindlimb morphogenesis
|
GO:0035137 |
2 |
0.877
|
|
|
|
salivary gland morphogenesis
|
GO:0007435 |
4 |
0.876
|
|
|
|
cell proliferation involved in heart valve development
|
GO:2000793 |
1 |
0.869
|
|
|
|
cardiac left ventricle formation
|
GO:0003218 |
1 |
0.852
|
|
|
|
nerve development
|
GO:0021675 |
4 |
0.850
|
|
|
|
negative regulation of muscle tissue development
|
GO:1901862 |
11 |
0.826
|
|
|
|
internal protein amino acid acetylation
|
GO:0006475 |
101 |
0.816
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
81 |
0.813
|
|
|
|
cranial nerve development
|
GO:0021545 |
4 |
0.805
|
|
|
|
positive regulation of chromatin assembly or disassembly
|
GO:0045799 |
2 |
0.755
|
|
|
|
aortic valve morphogenesis
|
GO:0003180 |
3 |
0.754
|
|
|
|
negative regulation of histone phosphorylation
|
GO:0033128 |
2 |
0.751
|
|
|
|
cell fate commitment involved in formation of primary germ layer
|
GO:0060795 |
6 |
0.738
|
|
|
|
eyelid development in camera type eye
|
GO:0061029 |
2 |
0.738
|
|
|
|
neural tube formation
|
GO:0001841 |
3 |
0.735
|
|
|
|
negative regulation of phosphatidylinositol 3 kinase signaling
|
GO:0014067 |
4 |
0.729
|
|
|
|
mitral valve development
|
GO:0003174 |
3 |
0.722
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
4 |
0.706
|
|
|
|
heart valve formation
|
GO:0003188 |
2 |
0.702
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
185 |
0.694
|
|
|
|
trophectodermal cell differentiation
|
GO:0001829 |
3 |
0.663
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
50 |
0.662
|
|
|
|
embryonic eye morphogenesis
|
GO:0048048 |
2 |
0.648
|
|
|
|
regulation of heart morphogenesis
|
GO:2000826 |
4 |
0.634
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
254 |
0.626
|
|
|
|
neural crest cell migration
|
GO:0001755 |
2 |
0.624
|
|
|
|
basophil differentiation
|
GO:0030221 |
2 |
0.612
|
|
|
|
positive regulation of stem cell differentiation
|
GO:2000738 |
29 |
0.599
|
|
|
|
chromatin modification
|
GO:0016568 |
298 |
0.588
|
|
|
|
craniofacial suture morphogenesis
|
GO:0097094 |
3 |
0.587
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
117 |
0.573
|
|
|
|
endocardial cushion development
|
GO:0003197 |
3 |
0.572
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
41 |
0.570
|
|
|
|
atrioventricular valve development
|
GO:0003171 |
3 |
0.569
|
|
|
|
embryonic camera type eye morphogenesis
|
GO:0048596 |
2 |
0.559
|
|
|
|
chromatin organization
|
GO:0006325 |
351 |
0.552
|
|
|
|
regulation of bone mineralization
|
GO:0030500 |
29 |
0.547
|
|
|
|
histone acetylation
|
GO:0016573 |
93 |
0.539
|
|
|
|
peptidyl lysine modification
|
GO:0018205 |
144 |
0.523
|
|
|
|
mesodermal cell differentiation
|
GO:0048333 |
10 |
0.499
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
80 |
0.486
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
4 |
0.474
|
|
|
|
mitral valve morphogenesis
|
GO:0003183 |
2 |
0.461
|
|
|
|
negative regulation of muscle organ development
|
GO:0048635 |
12 |
0.460
|
|
|
|
blastocyst formation
|
GO:0001825 |
3 |
0.451
|
|
|
|
negative regulation of sequence specific dna binding transcription factor activity
|
GO:0043433 |
89 |
0.449
|
|
|
|
cardiac septum morphogenesis
|
GO:0060411 |
9 |
0.444
|
|
|
|
embryonic cranial skeleton morphogenesis
|
GO:0048701 |
6 |
0.438
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
6 |
0.428
|
|
|
|
internal peptidyl lysine acetylation
|
GO:0018393 |
97 |
0.423
|
|
|
|
optic nerve development
|
GO:0021554 |
2 |
0.423
|
|
|
|
peptide transport
|
GO:0015833 |
74 |
0.422
|
|
|
|
lipid metabolic process
|
GO:0006629 |
381 |
0.417
|
|
|
|
regulation of biomineral tissue development
|
GO:0070167 |
31 |
0.417
|
|
|
|
chromatin assembly or disassembly
|
GO:0006333 |
78 |
0.415
|
|
|
|
positive regulation of myeloid cell differentiation
|
GO:0045639 |
39 |
0.414
|
|
|
|
peptidyl lysine acetylation
|
GO:0018394 |
101 |
0.411
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
26 |
0.402
|
|
|
|
primary neural tube formation
|
GO:0014020 |
3 |
0.394
|
|
|
|
negative regulation of skeletal muscle tissue development
|
GO:0048642 |
2 |
0.393
|
|
|
|
regulation of tumor necrosis factor superfamily cytokine production
|
GO:1903555 |
44 |
0.386
|
|
|
|
protein acylation
|
GO:0043543 |
138 |
0.376
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
11 |
0.374
|
|
|
|
amine metabolic process
|
GO:0009308 |
44 |
0.374
|
|
|
|
cerebellum development
|
GO:0021549 |
2 |
0.373
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
82 |
0.359
|
|
|
|
megakaryocyte differentiation
|
GO:0030219 |
25 |
0.356
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
3 |
0.355
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
211 |
0.347
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
303 |
0.345
|
|
|
|
positive regulation of epithelial to mesenchymal transition
|
GO:0010718 |
22 |
0.343
|
|
|
|
atrioventricular valve morphogenesis
|
GO:0003181 |
2 |
0.341
|
|
|
|
dna repair
|
GO:0006281 |
198 |
0.340
|
|
|
|
embryonic hindlimb morphogenesis
|
GO:0035116 |
2 |
0.339
|
|
|
|
regulation of lipid catabolic process
|
GO:0050994 |
23 |
0.336
|
|
|
|
peptide hormone secretion
|
GO:0030072 |
50 |
0.336
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
2 |
0.334
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
38 |
0.328
|
|
|
|
double strand break repair
|
GO:0006302 |
101 |
0.323
|
|
|
|
lipid catabolic process
|
GO:0016042 |
84 |
0.312
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
50 |
0.310
|
|
|
|
metencephalon development
|
GO:0022037 |
2 |
0.304
|
|
|
|
regulation of epithelial to mesenchymal transition
|
GO:0010717 |
37 |
0.303
|
|
|
|
immune system development
|
GO:0002520 |
195 |
0.300
|
|
|
|
positive regulation of lipid catabolic process
|
GO:0050996 |
13 |
0.299
|
|
|
|
neural tube closure
|
GO:0001843 |
3 |
0.293
|
|
|
|
positive regulation of cell morphogenesis involved in differentiation
|
GO:0010770 |
50 |
0.286
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
116 |
0.284
|
|
|
|
lipid modification
|
GO:0030258 |
84 |
0.279
|
|
|
|
negative regulation of transcription from rna polymerase ii promoter
|
GO:0000122 |
281 |
0.276
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
379 |
0.271
|
|
|
|
pancreas development
|
GO:0031016 |
19 |
0.270
|
|
|
|
embryonic digit morphogenesis
|
GO:0042733 |
6 |
0.266
|
|
|
|
carboxylic acid catabolic process
|
GO:0046395 |
71 |
0.265
|
|
|
|
regulation of tumor necrosis factor production
|
GO:0032680 |
43 |
0.264
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
125 |
0.264
|
|
|
|
regulation of dna repair
|
GO:0006282 |
47 |
0.264
|
|
|
|
dna damage response signal transduction by p53 class mediator
|
GO:0030330 |
44 |
0.262
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
189 |
0.262
|
|
|
|
positive regulation of erythrocyte differentiation
|
GO:0045648 |
11 |
0.261
|
|
|
|
cellular lipid catabolic process
|
GO:0044242 |
65 |
0.261
|
|
|
|
regulation of muscle organ development
|
GO:0048634 |
27 |
0.256
|
|
|
|
oxidation reduction process
|
GO:0055114 |
396 |
0.253
|
|
|
|
regulation of response to dna damage stimulus
|
GO:2001020 |
94 |
0.253
|
|
|
|
regulation of striated muscle tissue development
|
GO:0016202 |
26 |
0.248
|
|
|
|
cardiac chamber development
|
GO:0003205 |
30 |
0.242
|
|
|
|
positive regulation of binding
|
GO:0051099 |
45 |
0.242
|
|
|
|
regulation of stem cell differentiation
|
GO:2000736 |
56 |
0.239
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
78 |
0.235
|
|
|
|
small molecule catabolic process
|
GO:0044282 |
92 |
0.234
|
|
|
|
tube closure
|
GO:0060606 |
3 |
0.234
|
|
|
|
blastocyst development
|
GO:0001824 |
3 |
0.234
|
|
|
|
positive regulation of cellular component organization
|
GO:0051130 |
376 |
0.232
|
|
|
|
cytokine production
|
GO:0001816 |
247 |
0.227
|
|
|
|
ventricular cardiac muscle tissue morphogenesis
|
GO:0055010 |
14 |
0.226
|
|
|
|
muscle organ morphogenesis
|
GO:0048644 |
19 |
0.226
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
116 |
0.218
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
115 |
0.218
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
393 |
0.214
|
|
|
|
ventricular cardiac muscle tissue development
|
GO:0003229 |
14 |
0.214
|
|
|
|
peptide secretion
|
GO:0002790 |
51 |
0.213
|
|
|
|
regulation of fatty acid beta oxidation
|
GO:0031998 |
8 |
0.213
|
|
|
|
epithelial to mesenchymal transition
|
GO:0001837 |
48 |
0.207
|
|
|
|
organic acid catabolic process
|
GO:0016054 |
71 |
0.206
|
|
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
65 |
0.203
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
60 |
0.202
|
|
|
|
cation transport
|
GO:0006812 |
331 |
0.197
|
|
|
|
lipid oxidation
|
GO:0034440 |
33 |
0.195
|
|
|
|
regulation of transmembrane transporter activity
|
GO:0022898 |
74 |
0.194
|
|
|
|
regulation of double strand break repair
|
GO:2000779 |
22 |
0.194
|
|
|
|
hormone secretion
|
GO:0046879 |
65 |
0.194
|
|
|
|
regulation of protein localization
|
GO:0032880 |
296 |
0.189
|
|
|
|
bone mineralization
|
GO:0030282 |
34 |
0.189
|
|
|
|
negative regulation of transmembrane transport
|
GO:0034763 |
29 |
0.188
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
326 |
0.182
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
140 |
0.181
|
|
|
|
negative regulation of histone acetylation
|
GO:0035067 |
6 |
0.178
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
191 |
0.176
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
167 |
0.174
|
|
|
|
negative regulation of programmed cell death
|
GO:0043069 |
321 |
0.173
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
9 |
0.172
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
232 |
0.171
|
|
|
|
formation of primary germ layer
|
GO:0001704 |
42 |
0.168
|
|
|
|
negative regulation of tumor necrosis factor production
|
GO:0032720 |
20 |
0.168
|
|
|
|
stem cell development
|
GO:0048864 |
69 |
0.167
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
177 |
0.166
|
|
|
|
cell aging
|
GO:0007569 |
52 |
0.166
|
|
|
|
hemopoiesis
|
GO:0030097 |
180 |
0.164
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
23 |
0.164
|
|
|
|
mesoderm formation
|
GO:0001707 |
10 |
0.163
|
|
|
|
osteoblast differentiation
|
GO:0001649 |
92 |
0.162
|
|
|
|
fatty acid catabolic process
|
GO:0009062 |
29 |
0.161
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
242 |
0.159
|
|
|
|
odontogenesis
|
GO:0042476 |
25 |
0.159
|
|
|
|
regulation of transcription regulatory region dna binding
|
GO:2000677 |
15 |
0.159
|
|
|
|
amide transport
|
GO:0042886 |
76 |
0.158
|
|
|
|
chemokine production
|
GO:0032602 |
32 |
0.157
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
26 |
0.157
|
|
|
|
regulation of histone acetylation
|
GO:0035065 |
19 |
0.155
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
281 |
0.154
|
|
|
|
monocarboxylic acid catabolic process
|
GO:0072329 |
37 |
0.152
|
|
|
|
regulation of erythrocyte differentiation
|
GO:0045646 |
17 |
0.150
|
|
|
|
monovalent inorganic cation transport
|
GO:0015672 |
128 |
0.149
|
|
|
|
regulation of protein transport
|
GO:0051223 |
213 |
0.146
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
158 |
0.146
|
|
|
|
positive regulation of cellular component movement
|
GO:0051272 |
181 |
0.146
|
|
|
|
regulation of cytokine secretion
|
GO:0050707 |
57 |
0.143
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
391 |
0.142
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
96 |
0.142
|
|
|
|
positive regulation of dna binding
|
GO:0043388 |
17 |
0.142
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
108 |
0.142
|
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
131 |
0.142
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
353 |
0.141
|
|
|
|
regulation of dna binding
|
GO:0051101 |
37 |
0.141
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
139 |
0.141
|
|
|
|
monocyte chemotactic protein 1 production
|
GO:0071605 |
6 |
0.140
|
|
|
|
negative regulation of cell death
|
GO:0060548 |
345 |
0.138
|
|
|
|
positive regulation of transport
|
GO:0051050 |
336 |
0.137
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
195 |
0.136
|
|
|
|
positive regulation of cell proliferation
|
GO:0008284 |
301 |
0.135
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
9 |
0.135
|
|
|
|
regulation of secretion
|
GO:0051046 |
194 |
0.134
|
|
|
|
actin filament based process
|
GO:0030029 |
224 |
0.133
|
|
|
|
signal transduction in response to dna damage
|
GO:0042770 |
57 |
0.132
|
|
|
|
negative regulation of histone modification
|
GO:0031057 |
19 |
0.131
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
235 |
0.131
|
|
|
|
hematopoietic or lymphoid organ development
|
GO:0048534 |
186 |
0.131
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
39 |
0.131
|
|
|
|
regulation of ion transport
|
GO:0043269 |
189 |
0.131
|
|
|
|
hydrogen transport
|
GO:0006818 |
23 |
0.130
|
|
|
|
interleukin 6 production
|
GO:0032635 |
37 |
0.129
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.128
|
|
|
|
muscle tissue development
|
GO:0060537 |
62 |
0.128
|
|
|
|
negative regulation of cellular senescence
|
GO:2000773 |
5 |
0.127
|
|
|
|
positive regulation of catabolic process
|
GO:0009896 |
310 |
0.127
|
|
|
|
bone development
|
GO:0060348 |
26 |
0.127
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
177 |
0.127
|
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
52 |
0.123
|
|
|
|
regulation of cell differentiation
|
GO:0045595 |
393 |
0.123
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
135 |
0.122
|
|
|
|
hormone transport
|
GO:0009914 |
68 |
0.121
|
|
|
|
regulation of transporter activity
|
GO:0032409 |
82 |
0.121
|
|
|
|
gland morphogenesis
|
GO:0022612 |
8 |
0.119
|
|
|
|
regulation of cellular senescence
|
GO:2000772 |
13 |
0.118
|
|
|
|
histone modification
|
GO:0016570 |
251 |
0.117
|
|
|
|
cellular response to oxygen levels
|
GO:0071453 |
55 |
0.116
|
|
|
|
anatomical structure formation involved in morphogenesis
|
GO:0048646 |
284 |
0.116
|
|
|
|
signal release
|
GO:0023061 |
70 |
0.115
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
244 |
0.115
|
|
|
|
cellular response to decreased oxygen levels
|
GO:0036294 |
51 |
0.115
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
38 |
0.115
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
16 |
0.114
|
|
|
|
regulation of signal transduction by p53 class mediator
|
GO:1901796 |
26 |
0.113
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
284 |
0.111
|
|
|
|
regulation of peroxisome proliferator activated receptor signaling pathway
|
GO:0035358 |
4 |
0.110
|
|
|
|
erythrocyte homeostasis
|
GO:0034101 |
31 |
0.109
|
|
|
|
fatty acid oxidation
|
GO:0019395 |
31 |
0.109
|
|
|
|
positive regulation of fatty acid metabolic process
|
GO:0045923 |
11 |
0.108
|
|
|
|
negative regulation of developmental process
|
GO:0051093 |
247 |
0.108
|
|
|
|
cellular senescence
|
GO:0090398 |
34 |
0.108
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
83 |
0.107
|
|
|
|
positive regulation of locomotion
|
GO:0040017 |
186 |
0.106
|
|
|
|
proton transport
|
GO:0015992 |
22 |
0.106
|
|
|
|
positive regulation of fatty acid beta oxidation
|
GO:0032000 |
5 |
0.105
|
|
|
|
secretion by cell
|
GO:0032940 |
226 |
0.105
|
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
126 |
0.104
|
|
|
|
regulation of cellular component movement
|
GO:0051270 |
334 |
0.103
|
|
|
|
tumor necrosis factor superfamily cytokine production
|
GO:0071706 |
45 |
0.102
|
|
|
|
regulation of fatty acid metabolic process
|
GO:0019217 |
24 |
0.102
|
|
|
|
negative regulation of transport
|
GO:0051051 |
176 |
0.101
|
|
|
|
heart morphogenesis
|
GO:0003007 |
48 |
0.099
|
|
|
|
negative regulation of multicellular organismal process
|
GO:0051241 |
317 |
0.098
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
92 |
0.095
|
|
|
|
cellular response to hypoxia
|
GO:0071456 |
51 |
0.095
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
104 |
0.094
|
|
|
|
negative regulation of response to dna damage stimulus
|
GO:2001021 |
33 |
0.093
|
|
|
|
positive regulation of tumor necrosis factor superfamily cytokine production
|
GO:1903557 |
22 |
0.092
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
267 |
0.092
|
|
|
|
granulocyte differentiation
|
GO:0030851 |
16 |
0.092
|
|
|
|
positive regulation of protein secretion
|
GO:0050714 |
60 |
0.090
|
|
|
|
negative regulation of chromatin modification
|
GO:1903309 |
21 |
0.090
|
|
|
|
negative regulation of cell differentiation
|
GO:0045596 |
171 |
0.090
|
|
|
|
striated muscle cell differentiation
|
GO:0051146 |
43 |
0.090
|
|
|
|
epithelium development
|
GO:0060429 |
227 |
0.090
|
|
|
|
regulation of dna metabolic process
|
GO:0051052 |
153 |
0.089
|
|
|
|
biomineral tissue development
|
GO:0031214 |
39 |
0.089
|
|
|
|
muscle fiber development
|
GO:0048747 |
16 |
0.088
|
|
|
|
mesenchyme development
|
GO:0060485 |
59 |
0.086
|
|
|
|
tumor necrosis factor production
|
GO:0032640 |
43 |
0.086
|
|
|
|
palate development
|
GO:0060021 |
13 |
0.086
|
|
|
|
positive regulation of mitotic cell cycle
|
GO:0045931 |
60 |
0.085
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
183 |
0.085
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
86 |
0.085
|
|
|
|
regulation of cell motility
|
GO:2000145 |
299 |
0.085
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
140 |
0.083
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
174 |
0.083
|
|
|
|
negative regulation of transporter activity
|
GO:0032410 |
25 |
0.083
|
|
|
|
cell cell signaling
|
GO:0007267 |
155 |
0.082
|
|
|
|
negative regulation of chromosome organization
|
GO:2001251 |
48 |
0.081
|
|
|
|
positive regulation of transcription regulatory region dna binding
|
GO:2000679 |
8 |
0.080
|
|
|
|
signal transduction by p53 class mediator
|
GO:0072331 |
72 |
0.080
|
|
|
|
muscle cell development
|
GO:0055001 |
29 |
0.080
|
|
|
|
positive regulation of homeostatic process
|
GO:0032846 |
47 |
0.080
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
135 |
0.080
|
|
|
|
positive regulation of developmental process
|
GO:0051094 |
314 |
0.079
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
128 |
0.079
|
|
|
|
nervous system development
|
GO:0007399 |
293 |
0.078
|
|
|
|
cell division
|
GO:0051301 |
168 |
0.077
|
|
|
|
cellular component morphogenesis
|
GO:0032989 |
314 |
0.077
|
|
|
|
digestive tract development
|
GO:0048565 |
75 |
0.076
|
|
|
|
cardiac muscle tissue morphogenesis
|
GO:0055008 |
18 |
0.076
|
|
|
|
vasculature development
|
GO:0001944 |
181 |
0.075
|
|
|
|
regulation of cell morphogenesis
|
GO:0022604 |
153 |
0.075
|
|
|
|
cell fate determination
|
GO:0001709 |
3 |
0.075
|
|
|
|
gastrulation
|
GO:0007369 |
51 |
0.074
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
121 |
0.074
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
207 |
0.074
|
|
|
|
response to hypoxia
|
GO:0001666 |
96 |
0.074
|
|
|
|
regulation of locomotion
|
GO:0040012 |
329 |
0.072
|
|
|
|
positive regulation of chromosome organization
|
GO:2001252 |
41 |
0.071
|
|
|
|
cell morphogenesis
|
GO:0000902 |
296 |
0.071
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
63 |
0.071
|
|
|
|
positive regulation of cell division
|
GO:0051781 |
59 |
0.071
|
|
|
|
ossification
|
GO:0001503 |
121 |
0.070
|
|
|
|
muscle structure development
|
GO:0061061 |
98 |
0.070
|
|
|
|
cytokine secretion
|
GO:0050663 |
64 |
0.070
|
|
|
|
regulation of protein acetylation
|
GO:1901983 |
25 |
0.069
|
|
|
|
muscle tissue morphogenesis
|
GO:0060415 |
19 |
0.068
|
|
|
|
regulation of phosphatidylinositol 3 kinase signaling
|
GO:0014066 |
35 |
0.068
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
113 |
0.067
|
|
|
|
segmentation
|
GO:0035282 |
4 |
0.067
|
|
|
|
negative regulation of dna metabolic process
|
GO:0051053 |
57 |
0.067
|
|
|
|
negative regulation of ossification
|
GO:0030279 |
21 |
0.067
|
|
|
|
positive regulation of chemokine production
|
GO:0032722 |
22 |
0.066
|
|
|
|
cell development
|
GO:0048468 |
328 |
0.065
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
28 |
0.065
|
|
|
|
mesoderm morphogenesis
|
GO:0048332 |
11 |
0.065
|
|
|
|
blood vessel development
|
GO:0001568 |
172 |
0.065
|
|
|
|
cardiac septum development
|
GO:0003279 |
13 |
0.065
|
|
|
|
limb development
|
GO:0060173 |
23 |
0.064
|
|
|
|
regulation of chromatin assembly or disassembly
|
GO:0001672 |
6 |
0.064
|
|
|
|
post embryonic development
|
GO:0009791 |
2 |
0.063
|
|
|
|
positive regulation of tumor necrosis factor production
|
GO:0032760 |
21 |
0.063
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
96 |
0.063
|
|
|
|
protein secretion
|
GO:0009306 |
98 |
0.062
|
|
|
|
regulation of cell division
|
GO:0051302 |
116 |
0.062
|
|
|
|
fatty acid beta oxidation
|
GO:0006635 |
22 |
0.061
|
|
|
|
heart development
|
GO:0007507 |
95 |
0.061
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
56 |
0.059
|
|
|
|
regulation of anatomical structure morphogenesis
|
GO:0022603 |
286 |
0.059
|
|
|
|
regulation of cell development
|
GO:0060284 |
161 |
0.059
|
|
|
|
morphogenesis of an epithelium
|
GO:0002009 |
60 |
0.058
|
|
|
|
regulation of monocyte chemotactic protein 1 production
|
GO:0071637 |
6 |
0.057
|
|
|
|
limb morphogenesis
|
GO:0035108 |
16 |
0.057
|
|
|
|
positive regulation of interleukin 6 production
|
GO:0032755 |
21 |
0.057
|
|
|
|
regulation of peptidyl lysine acetylation
|
GO:2000756 |
22 |
0.056
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
23 |
0.056
|
|
|
|
regulation of interleukin 6 production
|
GO:0032675 |
37 |
0.055
|
|
|
|
muscle organ development
|
GO:0007517 |
56 |
0.054
|
|
|
|
behavior
|
GO:0007610 |
112 |
0.054
|
|
|
|
head development
|
GO:0060322 |
108 |
0.054
|
|
|
|
regulation of chromosome organization
|
GO:0033044 |
103 |
0.054
|
|
|
|
response to carbohydrate
|
GO:0009743 |
21 |
0.053
|
|
|
|
negative regulation of peptidyl lysine acetylation
|
GO:2000757 |
8 |
0.053
|
|
|
|
generation of neurons
|
GO:0048699 |
152 |
0.052
|
|
|
|
cardiovascular system development
|
GO:0072358 |
262 |
0.051
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
34 |
0.051
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
40 |
0.050
|
|
|
|
multicellular organismal aging
|
GO:0010259 |
3 |
0.050
|
|
|
|
response to growth factor
|
GO:0070848 |
205 |
0.050
|
|
|
|
central nervous system development
|
GO:0007417 |
123 |
0.050
|
|
|
|
negative regulation of protein acetylation
|
GO:1901984 |
11 |
0.050
|
|
|
|
response to oxygen levels
|
GO:0070482 |
100 |
0.049
|
|
|
|
bone morphogenesis
|
GO:0060349 |
10 |
0.049
|
|
|
|
neurogenesis
|
GO:0022008 |
169 |
0.049
|
|
|
|
regulation of skeletal muscle tissue development
|
GO:0048641 |
15 |
0.048
|
|
|
|
regulation of cell aging
|
GO:0090342 |
18 |
0.048
|
|
|
|
phosphatidylinositol mediated signaling
|
GO:0048015 |
55 |
0.048
|
|
|
|
retinoic acid biosynthetic process
|
GO:0002138 |
2 |
0.048
|
|
|
|
immune response
|
GO:0006955 |
307 |
0.047
|
|
|
|
stem cell differentiation
|
GO:0048863 |
93 |
0.047
|
|
|
|
tissue morphogenesis
|
GO:0048729 |
96 |
0.047
|
|
|
|
neural tube development
|
GO:0021915 |
9 |
0.047
|
|
|
|
vesicle mediated transport
|
GO:0016192 |
371 |
0.047
|
|
|
|
striated muscle cell development
|
GO:0055002 |
27 |
0.046
|
|
|
|
growth
|
GO:0040007 |
202 |
0.046
|
|
|
|
circulatory system development
|
GO:0072359 |
262 |
0.046
|
|
|
|
histone methylation
|
GO:0016571 |
60 |
0.045
|
|
|
|
organ morphogenesis
|
GO:0009887 |
147 |
0.045
|
|
|
|
brain development
|
GO:0007420 |
97 |
0.045
|
|
|
|
anatomical structure maturation
|
GO:0071695 |
9 |
0.045
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
24 |
0.044
|
|
|
|
tube development
|
GO:0035295 |
125 |
0.043
|
|
|
|
neuroblast proliferation
|
GO:0007405 |
4 |
0.043
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.043
|
|
|
|
histone phosphorylation
|
GO:0016572 |
16 |
0.043
|
|
|
|
gland development
|
GO:0048732 |
48 |
0.043
|
|
|
|
tube morphogenesis
|
GO:0035239 |
95 |
0.042
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
213 |
0.042
|
|
|
|
regulation of chromatin modification
|
GO:1903308 |
51 |
0.041
|
|
|
|
digestive system development
|
GO:0055123 |
75 |
0.041
|
|
|
|
regulation of chromatin organization
|
GO:1902275 |
56 |
0.041
|
|
|
|
positive regulation of cell differentiation
|
GO:0045597 |
211 |
0.040
|
|
|
|
phosphatidylinositol 3 kinase signaling
|
GO:0014065 |
48 |
0.040
|
|
|
|
regeneration
|
GO:0031099 |
4 |
0.040
|
|
|
|
protein catabolic process
|
GO:0030163 |
325 |
0.040
|
|
|
|
cellular macromolecular complex assembly
|
GO:0034622 |
324 |
0.040
|
|
|
|
embryonic morphogenesis
|
GO:0048598 |
85 |
0.039
|
|
|
|
regulation of histone modification
|
GO:0031056 |
47 |
0.039
|
|
|
|
reproductive process
|
GO:0022414 |
106 |
0.039
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
342 |
0.039
|
|
|
|
appendage development
|
GO:0048736 |
23 |
0.038
|
|
|
|
mesoderm development
|
GO:0007498 |
14 |
0.038
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
286 |
0.038
|
|
|
|
determination of adult lifespan
|
GO:0008340 |
2 |
0.038
|
|
|
|
negative regulation of catalytic activity
|
GO:0043086 |
335 |
0.038
|
|
|
|
negative regulation of tumor necrosis factor superfamily cytokine production
|
GO:1903556 |
20 |
0.038
|
|
|
|
eye morphogenesis
|
GO:0048592 |
16 |
0.037
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
13 |
0.037
|
|
|
|
cell morphogenesis involved in differentiation
|
GO:0000904 |
144 |
0.037
|
|
|
|
heart valve morphogenesis
|
GO:0003179 |
8 |
0.036
|
|
|
|
neural crest cell differentiation
|
GO:0014033 |
5 |
0.036
|
|
|
|
chordate embryonic development
|
GO:0043009 |
34 |
0.036
|
|
|
|
pharynx development
|
GO:0060465 |
1 |
0.035
|
|
|
|
actomyosin structure organization
|
GO:0031032 |
59 |
0.035
|
|
|
|
positive regulation of interleukin 6 secretion
|
GO:2000778 |
6 |
0.035
|
|
|
|
locomotory behavior
|
GO:0007626 |
1 |
0.035
|
|
|
|
histone lysine methylation
|
GO:0034968 |
50 |
0.034
|
|
|
|
female gamete generation
|
GO:0007292 |
2 |
0.034
|
|
|
|
inositol lipid mediated signaling
|
GO:0048017 |
55 |
0.033
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
379 |
0.033
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
412 |
0.032
|
|
|
|
membrane organization
|
GO:0061024 |
292 |
0.032
|
|
|
|
skeletal system development
|
GO:0001501 |
79 |
0.032
|
|
|
|
regulation of fatty acid oxidation
|
GO:0046320 |
9 |
0.032
|
|
|
|
methylation
|
GO:0032259 |
106 |
0.032
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
391 |
0.031
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
268 |
0.031
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
193 |
0.031
|
|
|
|
macromolecule methylation
|
GO:0043414 |
97 |
0.030
|
|
|
|
outflow tract morphogenesis
|
GO:0003151 |
10 |
0.030
|
|
|
|
single organism membrane organization
|
GO:0044802 |
268 |
0.030
|
|
|
|
response to monosaccharide
|
GO:0034284 |
20 |
0.030
|
|
|
|
protein processing
|
GO:0016485 |
226 |
0.030
|
|
|
|
neuron migration
|
GO:0001764 |
11 |
0.030
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
380 |
0.029
|
|
|
|
positive regulation of immune system process
|
GO:0002684 |
283 |
0.029
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.029
|
|
|
|
nitric oxide mediated signal transduction
|
GO:0007263 |
7 |
0.028
|
|
|
|
protein ubiquitination
|
GO:0016567 |
314 |
0.028
|
|
|
|
aging
|
GO:0007568 |
66 |
0.028
|
|
|
|
protein maturation
|
GO:0051604 |
233 |
0.028
|
|
|
|
forebrain generation of neurons
|
GO:0021872 |
3 |
0.028
|
|
|
|
cell adhesion
|
GO:0007155 |
325 |
0.028
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
411 |
0.028
|
|
|
|
oogenesis
|
GO:0048477 |
2 |
0.028
|
|
|
|
limbic system development
|
GO:0021761 |
3 |
0.028
|
|
|
|
developmental maturation
|
GO:0021700 |
28 |
0.027
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
266 |
0.027
|
|
|
|
response to abiotic stimulus
|
GO:0009628 |
336 |
0.027
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
119 |
0.027
|
|
|
|
protein acetylation
|
GO:0006473 |
116 |
0.027
|
|
|
|
response to hexose
|
GO:0009746 |
20 |
0.027
|
|
|
|
diterpenoid biosynthetic process
|
GO:0016102 |
2 |
0.027
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
212 |
0.027
|
|
|
|
protein polyubiquitination
|
GO:0000209 |
110 |
0.027
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
430 |
0.026
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
412 |
0.026
|
|
|
|
somitogenesis
|
GO:0001756 |
2 |
0.026
|
|
|
|
cell fate specification
|
GO:0001708 |
8 |
0.026
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
293 |
0.026
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
97 |
0.026
|
|
|
|
developmental programmed cell death
|
GO:0010623 |
3 |
0.026
|
|
|
|
epithelial cell differentiation
|
GO:0030855 |
141 |
0.026
|
|
|
|
stem cell division
|
GO:0017145 |
2 |
0.026
|
|
|
|
cardiac left ventricle morphogenesis
|
GO:0003214 |
6 |
0.025
|
|
|
|
single organism reproductive process
|
GO:0044702 |
98 |
0.025
|
|
|
|
biological adhesion
|
GO:0022610 |
331 |
0.025
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
182 |
0.025
|
|
|
|
microtubule based process
|
GO:0007017 |
210 |
0.025
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
261 |
0.025
|
|
|
|
tissue regeneration
|
GO:0042246 |
3 |
0.025
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
206 |
0.024
|
|
|
|
intracellular protein transport
|
GO:0006886 |
270 |
0.024
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
413 |
0.024
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
180 |
0.024
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
7 |
0.024
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
412 |
0.023
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
392 |
0.023
|
|
|
|
rna interference
|
GO:0016246 |
4 |
0.023
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
188 |
0.023
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
170 |
0.023
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
73 |
0.023
|
|
|
|
response to oxygen containing compound
|
GO:1901700 |
369 |
0.023
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
175 |
0.022
|
|
|
|
cellular response to endogenous stimulus
|
GO:0071495 |
336 |
0.022
|
|
|
|
regulation of cell migration
|
GO:0030334 |
289 |
0.022
|
|
|
|
embryo development
|
GO:0009790 |
123 |
0.022
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
398 |
0.022
|
|
|
|
negative regulation of locomotion
|
GO:0040013 |
118 |
0.022
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
411 |
0.022
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
209 |
0.022
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
195 |
0.022
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
156 |
0.021
|
|
|
|
hippocampus development
|
GO:0021766 |
1 |
0.021
|
|
|
|
forebrain neuron differentiation
|
GO:0021879 |
3 |
0.021
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
176 |
0.021
|
|
|
|
reproduction
|
GO:0000003 |
63 |
0.021
|
|
|
|
endomembrane system organization
|
GO:0010256 |
196 |
0.020
|
|
|
|
chemical homeostasis
|
GO:0048878 |
306 |
0.020
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
207 |
0.020
|
|
|
|
embryonic organ development
|
GO:0048568 |
36 |
0.020
|
|
|
|
secretion
|
GO:0046903 |
254 |
0.020
|
|
|
|
oocyte differentiation
|
GO:0009994 |
2 |
0.020
|
|
|
|
cd4 positive alpha beta t cell differentiation involved in immune response
|
GO:0002294 |
4 |
0.020
|
|
|
|
neural retina development
|
GO:0003407 |
8 |
0.020
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
391 |
0.020
|
|
